Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; other infectious disease vaccines for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia. more
Time Frame | GOVX | Sector | S&P500 |
---|---|---|---|
1-Week Return | -3.49% | -0.4% | -1.9% |
1-Month Return | -26.58% | -4.57% | -0.37% |
3-Month Return | -19.05% | -10.14% | 4.19% |
6-Month Return | -27.06% | -5.67% | 9.34% |
1-Year Return | -59.63% | 2.53% | 25.19% |
3-Year Return | -96.33% | -0.39% | 26.48% |
5-Year Return | -99.08% | 34.57% | 85.39% |
10-Year Return | -100% | 103.62% | 187.16% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 1.18M | 1.82M | 385.00K | 81.00K | - | [{"date":"2019-12-31","value":64.5,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":21.12,"profit":true},{"date":"2022-12-31","value":4.44,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | 1.91M | 2.44M | 15.55M | 56.28K | 20.72M | [{"date":"2019-12-31","value":9.22,"profit":true},{"date":"2020-12-31","value":11.8,"profit":true},{"date":"2021-12-31","value":75.07,"profit":true},{"date":"2022-12-31","value":0.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (734.82K) | 1.82M | 385.00K | 81.00K | (20.72M) | [{"date":"2019-12-31","value":-40.31,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":21.12,"profit":true},{"date":"2022-12-31","value":4.44,"profit":true},{"date":"2023-12-31","value":-1136.63,"profit":false}] |
Gross Margin | (62.49%) | 100.00% | 100.00% | 100.00% | - | [{"date":"2019-12-31","value":-62.49,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Operating Expenses | 3.55M | 4.64M | 19.13M | 14.11M | 6.02M | [{"date":"2019-12-31","value":18.55,"profit":true},{"date":"2020-12-31","value":24.25,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":73.75,"profit":true},{"date":"2023-12-31","value":31.48,"profit":true}] |
Operating Income | (2.37M) | (2.82M) | (18.75M) | (14.03M) | (26.74M) | [{"date":"2019-12-31","value":-237249300,"profit":false},{"date":"2020-12-31","value":-281700000,"profit":false},{"date":"2021-12-31","value":-1874600000,"profit":false},{"date":"2022-12-31","value":-1402900000,"profit":false},{"date":"2023-12-31","value":-2674293900,"profit":false}] |
Total Non-Operating Income/Expense | 3.73K | (282.25K) | 179.45K | 14.44K | 1.45M | [{"date":"2019-12-31","value":0.26,"profit":true},{"date":"2020-12-31","value":-19.4,"profit":false},{"date":"2021-12-31","value":12.34,"profit":true},{"date":"2022-12-31","value":0.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (2.37M) | (2.96M) | (18.57M) | (14.02M) | (25.97M) | [{"date":"2019-12-31","value":-237062900,"profit":false},{"date":"2020-12-31","value":-295800000,"profit":false},{"date":"2021-12-31","value":-1857000000,"profit":false},{"date":"2022-12-31","value":-1402200000,"profit":false},{"date":"2023-12-31","value":-2596676200,"profit":false}] |
Income Taxes | 4.50K | (19.66K) | (38.52K) | (7.44K) | 1.00 | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-437.29,"profit":false},{"date":"2021-12-31","value":-856.97,"profit":false},{"date":"2022-12-31","value":-165.49,"profit":false},{"date":"2023-12-31","value":0.02,"profit":true}] |
Income After Taxes | (2.38M) | (2.94M) | (18.53M) | (14.01M) | (25.97M) | [{"date":"2019-12-31","value":-237512400,"profit":false},{"date":"2020-12-31","value":-293834400,"profit":false},{"date":"2021-12-31","value":-1853147900,"profit":false},{"date":"2022-12-31","value":-1401456100,"profit":false},{"date":"2023-12-31","value":-2596676300,"profit":false}] |
Income From Continuous Operations | (2.37M) | (2.96M) | (18.57M) | (14.02M) | (23.76M) | [{"date":"2019-12-31","value":-237062900,"profit":false},{"date":"2020-12-31","value":-295806800,"profit":false},{"date":"2021-12-31","value":-1857000000,"profit":false},{"date":"2022-12-31","value":-1402112500,"profit":false},{"date":"2023-12-31","value":-2375816300,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (2.38M) | (2.94M) | (18.53M) | (14.01M) | (25.97M) | [{"date":"2019-12-31","value":-237512400,"profit":false},{"date":"2020-12-31","value":-293834400,"profit":false},{"date":"2021-12-31","value":-1853147900,"profit":false},{"date":"2022-12-31","value":-1401456100,"profit":false},{"date":"2023-12-31","value":-2596676200,"profit":false}] |
EPS (Diluted) | (98.80K) | (2.04) | (3.04) | (0.89) | (14.29) | [{"date":"2019-12-31","value":-9880252,"profit":false},{"date":"2020-12-31","value":-204,"profit":false},{"date":"2021-12-31","value":-304,"profit":false},{"date":"2022-12-31","value":-89,"profit":false},{"date":"2023-12-31","value":-1429,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
GOVX | |
---|---|
Cash Ratio | 3.29 |
Current Ratio | 4.17 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
GOVX | |
---|---|
ROA (LTM) | -134.35% |
ROE (LTM) | -362.39% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
GOVX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.23 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.77 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
GOVX | |
---|---|
Trailing PE | NM |
Forward PE | 10.63 |
P/S (TTM) | 69.36 |
P/B | 2.45 |
Price/FCF | NM |
EV/R | 6.29 |
EV/Ebitda | 0.10 |
PEG | NM |
GeoVax Labs Inc (GOVX) share price today is $2.255
Yes, Indians can buy shares of GeoVax Labs Inc (GOVX) on Vested. To buy GeoVax Labs Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GOVX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of GeoVax Labs Inc (GOVX) via the Vested app. You can start investing in GeoVax Labs Inc (GOVX) with a minimum investment of $1.
You can invest in shares of GeoVax Labs Inc (GOVX) via Vested in three simple steps:
The 52-week high price of GeoVax Labs Inc (GOVX) is $11.18. The 52-week low price of GeoVax Labs Inc (GOVX) is $1.09.
The price-to-earnings (P/E) ratio of GeoVax Labs Inc (GOVX) is
The price-to-book (P/B) ratio of GeoVax Labs Inc (GOVX) is 2.45
The dividend yield of GeoVax Labs Inc (GOVX) is 0.00%
The market capitalization of GeoVax Labs Inc (GOVX) is $20.85M
The stock symbol (or ticker) of GeoVax Labs Inc is GOVX